Morgan Stanley analyst Tejas Savant raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Adeptus Biotechnologies Corp. (ADPT) PT Raised to $14 at BTIGAugust 6, 2025 6:06 AM Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7cAugust 5, 2025 4:40 PM Form 10-Q Adaptive Biotechnologies For: Jun 30August 5, 2025 4:32 PM Form 8-K Adaptive Biotechnologies For: Aug 05August 5, 2025 4:16 PM Adaptive Biotechnologies Reports Second Quarter 2025 Financial ResultsAugust 5, 2025 4:05 PM